Literature DB >> 10755694

Idiopathic portal hypertension associated with systemic lupus erythematosus.

H Inagaki1, T Nonami, T Kawagoe, T Miwa, J Hosono, T Kurokawa, A Harada, A Nakao, H Takagi, H Suzuki, J Sakamoto.   

Abstract

A case of idiopathic portal hypertension (IPH) associated with systemic lupus erythematosus (SLE) is reported in a 38-year-old man who had been diagnosed with SLE and treated for 18 years. Esophageal varices. found in 1994 on endoscopic examination, had been followed up for 2 years. On July 16, 1996, he was admitted to Nagoya University Hospital because there was a high risk of bleeding from the esophageal varices due to severe thrombocytopenia. As partial splenic embolization had temporarily controlled the thrombocytopenia, splenectomy and devascularization of the stomach vessels were performed after endoscopic ligation of the esophageal varices. Histological specimens of wedge biopsied liver showed chronic inactive hepatitis without cirrhosis. The presence of anticardiolipin antibody, indicated by positivity for lupus anticoagulant, was suggestive of the presence of a common immunological mechanism in the etiology of SLE and IPH.

Entities:  

Mesh:

Year:  2000        PMID: 10755694     DOI: 10.1007/s005350050336

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  7 in total

Review 1.  Clinical characteristics of idiopathic portal hypertension.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

2.  Analgesics are not always the culprits: isolated gastric fundal varices as the cause of recurrent upper GI bleed in a patient with SLE, rheumatoid arthritis and polymyositis overlap syndrome.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Mohamad Ibrahim Fatani; Mazen G Bafaraj; Khalid Showkat; Sadia Hanif; Ahmad Qadmani; Mubeena Akhtar; Ghassan Al Maimani
Journal:  BMJ Case Rep       Date:  2009-08-10

3.  Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis.

Authors:  Aydin Seref Köksal; Seyfettin Köklü; Mehmet Ibiş; Mustafa Balci; Bahattin Ciçek; Nurgül Saşmaz; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

4.  Involvement of the liver in rheumatic diseases.

Authors:  Hiromasa Ohira; Kazumichi Abe; Atsushi Takahashi
Journal:  Clin J Gastroenterol       Date:  2011-11-26

5.  Idiopathic portal hypertension associated with systemic sclerosis and Sjögren's syndrome.

Authors:  Hiroyuki Kogawa; Kiyoshi Migita; Masahiro Ito; Yasushi Takii; Manabu Daikoku; Mikiko Nakao; Taichiro Miyashita; Hironori Kimura; Hironori Ezaki; Minoru Nakamura; Hiroshi Yatsuhashi; Katsumi Eguchi; Hiromi Ishibashi
Journal:  Clin Rheumatol       Date:  2005-05-05       Impact factor: 2.980

6.  Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature.

Authors:  Jan Däbritz; Jennifer Worch; Ulrike Materna; Bernward Koch; Gabriele Koehler; Christina Duck; Michael C Frühwald; Dirk Foell
Journal:  BMC Gastroenterol       Date:  2010-10-20       Impact factor: 3.067

7.  Systemic lupus erythematosus complicated by noncirrhotic portal hypertension: A case report and review of literature.

Authors:  Qi-Bin Yang; Yong-Long He; Chun-Mei Peng; Yu-Feng Qing; Qi He; Jing-Guo Zhou
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.